Medindia

X

3SBio Inc. Announces Filing of Form 20-F With SEC

Monday, June 28, 2010 General News J E 4
Advertisement
SHENYANG, China, June 28 3SBio Inc.(Nasdaq: SSRX) ("3SBio" or "the Company"), a leading China-based biotechnologycompany focused on researching, developing, manufacturing and marketingbiopharmaceutical products, today announced that on June 25, 2010, the Companyhas filed with the United States Securities and Exchange Commission its AnnualReport on Form 20-F for the year ended December 31, 2009 (the "2009 AnnualReport"). The 2009 Annual Report is available at the SEC's website( http://www.sec.gov ), the Company's website ( http://www.3sbio.com ) orhttp://tinyurl.com/3Sbio2009

Hard copies of the 2009 Annual Report are available free of charge to ourshareholders and ADS holders, upon written request by contacting ir@3SBio.com.For more information, please contact: Investor Contacts Bo Tan Chief Financial Officer 3SBio Inc. Tel: +86-24-2581-1820 Email: ir@3SBio.com Tom Folinsbee Director of Investor Relations 3SBio Inc. Tel: +852-8191-6991 Email: ir@3SBio.com

SOURCE 3SBio Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Solta Medical Announces Thermage CPT(TM) and Fraxe...
S
Quark Pharmaceutical's QPI-1007 Exhibits Neuroprot...